Novartis has made a decision. The pharmaceutical company will use the proceeds from the sale of Roche’s bearer shares to buy back its own shares for USD 15 billion. The transaction is expected to be completed by the end of 2023, Novartis announced on Thursday.
source site-15
After Roche sale: Novartis buys back shares on a large scale
